Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors [Yahoo! Finance]
Talphera, Inc. (TLPH)
Company Research
Source: Yahoo! Finance
Both appointees bring extensive experience in the finance, investment, business development, and strategic management in the global biopharmaceutical sector. The company believes their expertise will help propel its growth, particularly as it advances its global innovation strategy. Ms. Bozilenko and Dr. Yu have held various leadership positions at notable companies, including Biothea Pharma, Talphera, Inc., and Panacea Venture. ROCKVILLE, Md. and SUZHOU, China Nov. 25, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. Marina S. Bozilenko and Dr. Debra Yu as additional independent non-executive directors of the company with effect from November 25, 2024 "I would like to extend a warm welcome to Ms. Marina S. Bozilenko and Dr. Debra Yu , who are joining Ascentage Pharma as indep
Show less
Read more
Impact Snapshot
Event Time:
TLPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TLPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TLPH alerts
High impacting Talphera, Inc. news events
Weekly update
A roundup of the hottest topics
TLPH
News
- Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive DirectorsPR Newswire
- Talphera Inc (TLPH) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges [Yahoo! Finance]Yahoo! Finance
- Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate UpdatePR Newswire
- Talphera, Inc. (NASDAQ: TLPH) was upgraded by analysts at Maxim Group to a "strong-buy" rating.MarketBeat
- Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024PR Newswire
TLPH
Earnings
- 11/13/24 - Beat
TLPH
Analyst Actions
- 11/12/24 - Maxim Group
TLPH
Sec Filings
- 12/11/24 - Form 8-K
- 12/6/24 - Form 4
- 12/2/24 - Form 4
- TLPH's page on the SEC website